Infection Prevention & Control Conference 2026
Over two days, IPC 2026 delivers expert-led sessions, practical workshops, and real-world case studies focused on the biggest challenges in infection prevention. From HCAIs and emerging threats to antimicrobial resistance and outbreak response, the agenda is built to inform, inspire, and support best practice across the NHS.
Mölnlycke’s Antiseptics division will be showcasing evidence based solutions that improve infection prevention standards across healthcare. Our portfolio includes Hibiwash, a 4% chlorhexidine full body antimicrobial wash, and Steriwave, an advanced nasal photodisinfection technology designed to support safer surgical pathways. We work closely with clinicians, infection prevention teams and health systems to reduce infection risk, improve patient outcomes and support operational efficiency. Our focus is on delivering reliable, clinically supported technologies that integrate smoothly into existing hospital workflows.
Visit the Mölnlycke stand and talk to our experts.
Find out more here: https://www.infectionpreventioncontrol.net/